Volume 86, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



The main causative agent of cutaneous leishmaniasis (CL) in Suriname is () . This case report presents a patient infected with () , a species never reported before in Suriname. This finding has clinical implications, because has a distinct clinical phenotype characterized by mucocutaneous leishmaniasis, a more extensive and destructive form of CL that requires different treatment. Clinicians should be aware that chronic cutaneous ulcers in patients from the Guyana region could be caused by .


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Flu PC, , 1911. Die aetiologie der in Surinam vorkommenden sogenannten “Boschyaws,” einer der Aleppobeule analogen Erkrankung. Centralbl Bakt parasit Kde Orig 60: 624637. [Google Scholar]
  2. Lai A Fat EJ, Vrede MA, Soetosenojo RM, Lai A Fat RF, , 2002. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 41: 796800.[Crossref] [Google Scholar]
  3. van der Meide WF, de Vries H, Pratlong F, van der Wal A, Sabajo L, , 2008. Leishmania (Leishmania) amazonensis infection in Suriname. Emerg Infect Dis 14: 857859.[Crossref] [Google Scholar]
  4. van Thiel PP, Gool T, Kager PA, Bart A, , 2010. First cases of cutaneous leishmaniasis caused by Leishmania (Viannia) naiffi infection in Surinam. Am J Trop Med Hyg 82: 588590.[Crossref] [Google Scholar]
  5. van der Meide WF, Schoone GJ, Faber WR, Zeegelaar JE, de Vries HJ, Schallig HD, Ozbel Y, Lai A Fat RF, Coelho LJ, Kassi M, Schallig HD, , 2005. Quantitative nucleic acid sequence-based assay as a new molecular tool for the detection and qualification of Leishmania parasites in skin biopsies. J Clin Microbiol 43: 55605566.[Crossref] [Google Scholar]
  6. Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HDFH, Presber W, Jaffe CL, , 2003. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 47: 349358.[Crossref] [Google Scholar]
  7. World Health Organization, 1990. Control of the leishmaniasis. World Health Organ Tech Rep Ser 48: 793. [Google Scholar]
  8. Boom R, Sol C, Salimans M, Jansen C, Wertheim van Dillen P, van der Noordaa L, , 1990. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495503. [Google Scholar]
  9. Marfurt J, Niederwieser I, Makia N, Beck H, Felger I, , 2003. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis 46: 115124.[Crossref] [Google Scholar]
  10. Grimaldi G, Jr Mahan-Pratt D, , 1991. Leishmaniasis and its etiologic agents in the New World: an overview. Prog Clin Parasitol 2: 73118. [Google Scholar]
  11. Jones TC, Johnson WD, Jr Bareto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF, , 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis . J Infect Dis 156: 7383.[Crossref] [Google Scholar]
  12. Rotureau B, , 2006. Ecology of the Leishmania species in the Guianan ecoregion complex. Am J Trop Med 74: 8196. [Google Scholar]
  13. van der Meide WF, Jensema AJ, Akrum RA, Sabajo LO, Lai A Fat RF, Lambregts L, Schallig HD, van der Paardt M, Faber WR, , 2008. Epidemiology of cutaneous leishmaniasis in Suriname: a study performed in 2006. Am J Trop Med Hyg 79: 192197. [Google Scholar]
  14. Machado PR, Ampeuro J, Guimaraes LH, Villasboas L, Rocha AT, Schriefer A, Sousa RS, Talhari A, Penna G, Carvalho EM, , 2010. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS Negl Trop Dis 4: e912.[Crossref] [Google Scholar]
  15. Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD, , 2005. Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis. Am J Trop Med Hyg 72: 133137. [Google Scholar]
  16. World Health Organization, 2010. Control of the leishmaniasis. World Health Organ Tech Rep Ser 949: 6271. [Google Scholar]
  17. Lessa MM, Lessa HA, Castro TW, Oliveira A, Scherifer A, Machado P, Carvalho EM, , 2007. Mucosal leishmaniasis: epidemiological and clinical aspects. Braz J Otorhinolaryngol 73: 843847.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 23 Nov 2011
  • Accepted : 06 Feb 2012
  • Published online : 01 May 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error